Global Human Vaccination Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Human Vaccination market size was valued at US$ 61700 million in 2024 and is forecast to a readjusted size of USD 78630 million by 2031 with a CAGR of 3.6% during review period.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Human Vaccination market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Vaccination market size and forecasts, in consumption value ($ Million), 2020-2031
Global Human Vaccination market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Human Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Human Vaccination market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Vaccination
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Vaccination market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac, NCPC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Human Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Inactivated Vaccine
- Live-attenuated Vaccine
- mRNA Vaccine
- Conjugate Vaccine
- Other
Market segment by Application
- Government Institution
- Private Sector
- Other
Market segment by players, this report covers
- GSK
- Merck
- Sanofi
- Sinovac
- Zhejiang Pukang
- Changchun Institute of Biological
- KM Biologics
- IMBCAMS
- Convac
- NCPC
- Bio Kangtai
- Dynavax
- Hissen
- KM Biologics
- LG Life Sciences
- Serum Institute
- Pfizer
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Vaccination product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Vaccination, with revenue, gross margin, and global market share of Human Vaccination from 2020 to 2025.
Chapter 3, the Human Vaccination competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Human Vaccination market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Vaccination.
Chapter 13, to describe Human Vaccination research findings and conclusion.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Human Vaccination market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Vaccination market size and forecasts, in consumption value ($ Million), 2020-2031
Global Human Vaccination market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Human Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Human Vaccination market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Vaccination
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Vaccination market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac, NCPC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Human Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Inactivated Vaccine
- Live-attenuated Vaccine
- mRNA Vaccine
- Conjugate Vaccine
- Other
Market segment by Application
- Government Institution
- Private Sector
- Other
Market segment by players, this report covers
- GSK
- Merck
- Sanofi
- Sinovac
- Zhejiang Pukang
- Changchun Institute of Biological
- KM Biologics
- IMBCAMS
- Convac
- NCPC
- Bio Kangtai
- Dynavax
- Hissen
- KM Biologics
- LG Life Sciences
- Serum Institute
- Pfizer
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Vaccination product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Vaccination, with revenue, gross margin, and global market share of Human Vaccination from 2020 to 2025.
Chapter 3, the Human Vaccination competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Human Vaccination market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Vaccination.
Chapter 13, to describe Human Vaccination research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Human Vaccination by Type
1.3.1 Overview: Global Human Vaccination Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Human Vaccination Consumption Value Market Share by Type in 2024
1.3.3 Inactivated Vaccine
1.3.4 Live-attenuated Vaccine
1.3.5 mRNA Vaccine
1.3.6 Conjugate Vaccine
1.3.7 Other
1.4 Global Human Vaccination Market by Application
1.4.1 Overview: Global Human Vaccination Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Government Institution
1.4.3 Private Sector
1.4.4 Other
1.5 Global Human Vaccination Market Size & Forecast
1.6 Global Human Vaccination Market Size and Forecast by Region
1.6.1 Global Human Vaccination Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Human Vaccination Market Size by Region, (2020-2031)
1.6.3 North America Human Vaccination Market Size and Prospect (2020-2031)
1.6.4 Europe Human Vaccination Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Human Vaccination Market Size and Prospect (2020-2031)
1.6.6 South America Human Vaccination Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Human Vaccination Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Human Vaccination Product and Solutions
2.1.4 GSK Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 GSK Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Human Vaccination Product and Solutions
2.2.4 Merck Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Merck Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Human Vaccination Product and Solutions
2.3.4 Sanofi Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Sinovac
2.4.1 Sinovac Details
2.4.2 Sinovac Major Business
2.4.3 Sinovac Human Vaccination Product and Solutions
2.4.4 Sinovac Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Sinovac Recent Developments and Future Plans
2.5 Zhejiang Pukang
2.5.1 Zhejiang Pukang Details
2.5.2 Zhejiang Pukang Major Business
2.5.3 Zhejiang Pukang Human Vaccination Product and Solutions
2.5.4 Zhejiang Pukang Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Zhejiang Pukang Recent Developments and Future Plans
2.6 Changchun Institute of Biological
2.6.1 Changchun Institute of Biological Details
2.6.2 Changchun Institute of Biological Major Business
2.6.3 Changchun Institute of Biological Human Vaccination Product and Solutions
2.6.4 Changchun Institute of Biological Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Changchun Institute of Biological Recent Developments and Future Plans
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Human Vaccination Product and Solutions
2.7.4 KM Biologics Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 KM Biologics Recent Developments and Future Plans
2.8 IMBCAMS
2.8.1 IMBCAMS Details
2.8.2 IMBCAMS Major Business
2.8.3 IMBCAMS Human Vaccination Product and Solutions
2.8.4 IMBCAMS Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 IMBCAMS Recent Developments and Future Plans
2.9 Convac
2.9.1 Convac Details
2.9.2 Convac Major Business
2.9.3 Convac Human Vaccination Product and Solutions
2.9.4 Convac Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Convac Recent Developments and Future Plans
2.10 NCPC
2.10.1 NCPC Details
2.10.2 NCPC Major Business
2.10.3 NCPC Human Vaccination Product and Solutions
2.10.4 NCPC Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 NCPC Recent Developments and Future Plans
2.11 Bio Kangtai
2.11.1 Bio Kangtai Details
2.11.2 Bio Kangtai Major Business
2.11.3 Bio Kangtai Human Vaccination Product and Solutions
2.11.4 Bio Kangtai Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Bio Kangtai Recent Developments and Future Plans
2.12 Dynavax
2.12.1 Dynavax Details
2.12.2 Dynavax Major Business
2.12.3 Dynavax Human Vaccination Product and Solutions
2.12.4 Dynavax Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Dynavax Recent Developments and Future Plans
2.13 Hissen
2.13.1 Hissen Details
2.13.2 Hissen Major Business
2.13.3 Hissen Human Vaccination Product and Solutions
2.13.4 Hissen Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Hissen Recent Developments and Future Plans
2.14 KM Biologics
2.14.1 KM Biologics Details
2.14.2 KM Biologics Major Business
2.14.3 KM Biologics Human Vaccination Product and Solutions
2.14.4 KM Biologics Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 KM Biologics Recent Developments and Future Plans
2.15 LG Life Sciences
2.15.1 LG Life Sciences Details
2.15.2 LG Life Sciences Major Business
2.15.3 LG Life Sciences Human Vaccination Product and Solutions
2.15.4 LG Life Sciences Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 LG Life Sciences Recent Developments and Future Plans
2.16 Serum Institute
2.16.1 Serum Institute Details
2.16.2 Serum Institute Major Business
2.16.3 Serum Institute Human Vaccination Product and Solutions
2.16.4 Serum Institute Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Serum Institute Recent Developments and Future Plans
2.17 Pfizer
2.17.1 Pfizer Details
2.17.2 Pfizer Major Business
2.17.3 Pfizer Human Vaccination Product and Solutions
2.17.4 Pfizer Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Pfizer Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Human Vaccination Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Human Vaccination by Company Revenue
3.2.2 Top 3 Human Vaccination Players Market Share in 2024
3.2.3 Top 6 Human Vaccination Players Market Share in 2024
3.3 Human Vaccination Market: Overall Company Footprint Analysis
3.3.1 Human Vaccination Market: Region Footprint
3.3.2 Human Vaccination Market: Company Product Type Footprint
3.3.3 Human Vaccination Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Human Vaccination Consumption Value and Market Share by Type (2020-2025)
4.2 Global Human Vaccination Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Human Vaccination Consumption Value Market Share by Application (2020-2025)
5.2 Global Human Vaccination Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Human Vaccination Consumption Value by Type (2020-2031)
6.2 North America Human Vaccination Market Size by Application (2020-2031)
6.3 North America Human Vaccination Market Size by Country
6.3.1 North America Human Vaccination Consumption Value by Country (2020-2031)
6.3.2 United States Human Vaccination Market Size and Forecast (2020-2031)
6.3.3 Canada Human Vaccination Market Size and Forecast (2020-2031)
6.3.4 Mexico Human Vaccination Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Human Vaccination Consumption Value by Type (2020-2031)
7.2 Europe Human Vaccination Consumption Value by Application (2020-2031)
7.3 Europe Human Vaccination Market Size by Country
7.3.1 Europe Human Vaccination Consumption Value by Country (2020-2031)
7.3.2 Germany Human Vaccination Market Size and Forecast (2020-2031)
7.3.3 France Human Vaccination Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Human Vaccination Market Size and Forecast (2020-2031)
7.3.5 Russia Human Vaccination Market Size and Forecast (2020-2031)
7.3.6 Italy Human Vaccination Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Human Vaccination Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Human Vaccination Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Human Vaccination Market Size by Region
8.3.1 Asia-Pacific Human Vaccination Consumption Value by Region (2020-2031)
8.3.2 China Human Vaccination Market Size and Forecast (2020-2031)
8.3.3 Japan Human Vaccination Market Size and Forecast (2020-2031)
8.3.4 South Korea Human Vaccination Market Size and Forecast (2020-2031)
8.3.5 India Human Vaccination Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Human Vaccination Market Size and Forecast (2020-2031)
8.3.7 Australia Human Vaccination Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Human Vaccination Consumption Value by Type (2020-2031)
9.2 South America Human Vaccination Consumption Value by Application (2020-2031)
9.3 South America Human Vaccination Market Size by Country
9.3.1 South America Human Vaccination Consumption Value by Country (2020-2031)
9.3.2 Brazil Human Vaccination Market Size and Forecast (2020-2031)
9.3.3 Argentina Human Vaccination Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Human Vaccination Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Human Vaccination Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Human Vaccination Market Size by Country
10.3.1 Middle East & Africa Human Vaccination Consumption Value by Country (2020-2031)
10.3.2 Turkey Human Vaccination Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Human Vaccination Market Size and Forecast (2020-2031)
10.3.4 UAE Human Vaccination Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Human Vaccination Market Drivers
11.2 Human Vaccination Market Restraints
11.3 Human Vaccination Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Human Vaccination Industry Chain
12.2 Human Vaccination Upstream Analysis
12.3 Human Vaccination Midstream Analysis
12.4 Human Vaccination Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Human Vaccination by Type
1.3.1 Overview: Global Human Vaccination Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Human Vaccination Consumption Value Market Share by Type in 2024
1.3.3 Inactivated Vaccine
1.3.4 Live-attenuated Vaccine
1.3.5 mRNA Vaccine
1.3.6 Conjugate Vaccine
1.3.7 Other
1.4 Global Human Vaccination Market by Application
1.4.1 Overview: Global Human Vaccination Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Government Institution
1.4.3 Private Sector
1.4.4 Other
1.5 Global Human Vaccination Market Size & Forecast
1.6 Global Human Vaccination Market Size and Forecast by Region
1.6.1 Global Human Vaccination Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Human Vaccination Market Size by Region, (2020-2031)
1.6.3 North America Human Vaccination Market Size and Prospect (2020-2031)
1.6.4 Europe Human Vaccination Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Human Vaccination Market Size and Prospect (2020-2031)
1.6.6 South America Human Vaccination Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Human Vaccination Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Human Vaccination Product and Solutions
2.1.4 GSK Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 GSK Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Human Vaccination Product and Solutions
2.2.4 Merck Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Merck Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Human Vaccination Product and Solutions
2.3.4 Sanofi Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Sinovac
2.4.1 Sinovac Details
2.4.2 Sinovac Major Business
2.4.3 Sinovac Human Vaccination Product and Solutions
2.4.4 Sinovac Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Sinovac Recent Developments and Future Plans
2.5 Zhejiang Pukang
2.5.1 Zhejiang Pukang Details
2.5.2 Zhejiang Pukang Major Business
2.5.3 Zhejiang Pukang Human Vaccination Product and Solutions
2.5.4 Zhejiang Pukang Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Zhejiang Pukang Recent Developments and Future Plans
2.6 Changchun Institute of Biological
2.6.1 Changchun Institute of Biological Details
2.6.2 Changchun Institute of Biological Major Business
2.6.3 Changchun Institute of Biological Human Vaccination Product and Solutions
2.6.4 Changchun Institute of Biological Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Changchun Institute of Biological Recent Developments and Future Plans
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Human Vaccination Product and Solutions
2.7.4 KM Biologics Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 KM Biologics Recent Developments and Future Plans
2.8 IMBCAMS
2.8.1 IMBCAMS Details
2.8.2 IMBCAMS Major Business
2.8.3 IMBCAMS Human Vaccination Product and Solutions
2.8.4 IMBCAMS Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 IMBCAMS Recent Developments and Future Plans
2.9 Convac
2.9.1 Convac Details
2.9.2 Convac Major Business
2.9.3 Convac Human Vaccination Product and Solutions
2.9.4 Convac Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Convac Recent Developments and Future Plans
2.10 NCPC
2.10.1 NCPC Details
2.10.2 NCPC Major Business
2.10.3 NCPC Human Vaccination Product and Solutions
2.10.4 NCPC Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 NCPC Recent Developments and Future Plans
2.11 Bio Kangtai
2.11.1 Bio Kangtai Details
2.11.2 Bio Kangtai Major Business
2.11.3 Bio Kangtai Human Vaccination Product and Solutions
2.11.4 Bio Kangtai Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Bio Kangtai Recent Developments and Future Plans
2.12 Dynavax
2.12.1 Dynavax Details
2.12.2 Dynavax Major Business
2.12.3 Dynavax Human Vaccination Product and Solutions
2.12.4 Dynavax Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Dynavax Recent Developments and Future Plans
2.13 Hissen
2.13.1 Hissen Details
2.13.2 Hissen Major Business
2.13.3 Hissen Human Vaccination Product and Solutions
2.13.4 Hissen Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Hissen Recent Developments and Future Plans
2.14 KM Biologics
2.14.1 KM Biologics Details
2.14.2 KM Biologics Major Business
2.14.3 KM Biologics Human Vaccination Product and Solutions
2.14.4 KM Biologics Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 KM Biologics Recent Developments and Future Plans
2.15 LG Life Sciences
2.15.1 LG Life Sciences Details
2.15.2 LG Life Sciences Major Business
2.15.3 LG Life Sciences Human Vaccination Product and Solutions
2.15.4 LG Life Sciences Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 LG Life Sciences Recent Developments and Future Plans
2.16 Serum Institute
2.16.1 Serum Institute Details
2.16.2 Serum Institute Major Business
2.16.3 Serum Institute Human Vaccination Product and Solutions
2.16.4 Serum Institute Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Serum Institute Recent Developments and Future Plans
2.17 Pfizer
2.17.1 Pfizer Details
2.17.2 Pfizer Major Business
2.17.3 Pfizer Human Vaccination Product and Solutions
2.17.4 Pfizer Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Pfizer Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Human Vaccination Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Human Vaccination by Company Revenue
3.2.2 Top 3 Human Vaccination Players Market Share in 2024
3.2.3 Top 6 Human Vaccination Players Market Share in 2024
3.3 Human Vaccination Market: Overall Company Footprint Analysis
3.3.1 Human Vaccination Market: Region Footprint
3.3.2 Human Vaccination Market: Company Product Type Footprint
3.3.3 Human Vaccination Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Human Vaccination Consumption Value and Market Share by Type (2020-2025)
4.2 Global Human Vaccination Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Human Vaccination Consumption Value Market Share by Application (2020-2025)
5.2 Global Human Vaccination Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Human Vaccination Consumption Value by Type (2020-2031)
6.2 North America Human Vaccination Market Size by Application (2020-2031)
6.3 North America Human Vaccination Market Size by Country
6.3.1 North America Human Vaccination Consumption Value by Country (2020-2031)
6.3.2 United States Human Vaccination Market Size and Forecast (2020-2031)
6.3.3 Canada Human Vaccination Market Size and Forecast (2020-2031)
6.3.4 Mexico Human Vaccination Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Human Vaccination Consumption Value by Type (2020-2031)
7.2 Europe Human Vaccination Consumption Value by Application (2020-2031)
7.3 Europe Human Vaccination Market Size by Country
7.3.1 Europe Human Vaccination Consumption Value by Country (2020-2031)
7.3.2 Germany Human Vaccination Market Size and Forecast (2020-2031)
7.3.3 France Human Vaccination Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Human Vaccination Market Size and Forecast (2020-2031)
7.3.5 Russia Human Vaccination Market Size and Forecast (2020-2031)
7.3.6 Italy Human Vaccination Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Human Vaccination Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Human Vaccination Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Human Vaccination Market Size by Region
8.3.1 Asia-Pacific Human Vaccination Consumption Value by Region (2020-2031)
8.3.2 China Human Vaccination Market Size and Forecast (2020-2031)
8.3.3 Japan Human Vaccination Market Size and Forecast (2020-2031)
8.3.4 South Korea Human Vaccination Market Size and Forecast (2020-2031)
8.3.5 India Human Vaccination Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Human Vaccination Market Size and Forecast (2020-2031)
8.3.7 Australia Human Vaccination Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Human Vaccination Consumption Value by Type (2020-2031)
9.2 South America Human Vaccination Consumption Value by Application (2020-2031)
9.3 South America Human Vaccination Market Size by Country
9.3.1 South America Human Vaccination Consumption Value by Country (2020-2031)
9.3.2 Brazil Human Vaccination Market Size and Forecast (2020-2031)
9.3.3 Argentina Human Vaccination Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Human Vaccination Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Human Vaccination Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Human Vaccination Market Size by Country
10.3.1 Middle East & Africa Human Vaccination Consumption Value by Country (2020-2031)
10.3.2 Turkey Human Vaccination Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Human Vaccination Market Size and Forecast (2020-2031)
10.3.4 UAE Human Vaccination Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Human Vaccination Market Drivers
11.2 Human Vaccination Market Restraints
11.3 Human Vaccination Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Human Vaccination Industry Chain
12.2 Human Vaccination Upstream Analysis
12.3 Human Vaccination Midstream Analysis
12.4 Human Vaccination Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Vaccination Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Human Vaccination Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Human Vaccination Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Human Vaccination Consumption Value by Region (2026-2031) & (USD Million)
Table 5. GSK Company Information, Head Office, and Major Competitors
Table 6. GSK Major Business
Table 7. GSK Human Vaccination Product and Solutions
Table 8. GSK Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. GSK Recent Developments and Future Plans
Table 10. Merck Company Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Human Vaccination Product and Solutions
Table 13. Merck Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Merck Recent Developments and Future Plans
Table 15. Sanofi Company Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Human Vaccination Product and Solutions
Table 18. Sanofi Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Sinovac Company Information, Head Office, and Major Competitors
Table 20. Sinovac Major Business
Table 21. Sinovac Human Vaccination Product and Solutions
Table 22. Sinovac Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Sinovac Recent Developments and Future Plans
Table 24. Zhejiang Pukang Company Information, Head Office, and Major Competitors
Table 25. Zhejiang Pukang Major Business
Table 26. Zhejiang Pukang Human Vaccination Product and Solutions
Table 27. Zhejiang Pukang Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Zhejiang Pukang Recent Developments and Future Plans
Table 29. Changchun Institute of Biological Company Information, Head Office, and Major Competitors
Table 30. Changchun Institute of Biological Major Business
Table 31. Changchun Institute of Biological Human Vaccination Product and Solutions
Table 32. Changchun Institute of Biological Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Changchun Institute of Biological Recent Developments and Future Plans
Table 34. KM Biologics Company Information, Head Office, and Major Competitors
Table 35. KM Biologics Major Business
Table 36. KM Biologics Human Vaccination Product and Solutions
Table 37. KM Biologics Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. KM Biologics Recent Developments and Future Plans
Table 39. IMBCAMS Company Information, Head Office, and Major Competitors
Table 40. IMBCAMS Major Business
Table 41. IMBCAMS Human Vaccination Product and Solutions
Table 42. IMBCAMS Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. IMBCAMS Recent Developments and Future Plans
Table 44. Convac Company Information, Head Office, and Major Competitors
Table 45. Convac Major Business
Table 46. Convac Human Vaccination Product and Solutions
Table 47. Convac Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Convac Recent Developments and Future Plans
Table 49. NCPC Company Information, Head Office, and Major Competitors
Table 50. NCPC Major Business
Table 51. NCPC Human Vaccination Product and Solutions
Table 52. NCPC Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. NCPC Recent Developments and Future Plans
Table 54. Bio Kangtai Company Information, Head Office, and Major Competitors
Table 55. Bio Kangtai Major Business
Table 56. Bio Kangtai Human Vaccination Product and Solutions
Table 57. Bio Kangtai Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Bio Kangtai Recent Developments and Future Plans
Table 59. Dynavax Company Information, Head Office, and Major Competitors
Table 60. Dynavax Major Business
Table 61. Dynavax Human Vaccination Product and Solutions
Table 62. Dynavax Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Dynavax Recent Developments and Future Plans
Table 64. Hissen Company Information, Head Office, and Major Competitors
Table 65. Hissen Major Business
Table 66. Hissen Human Vaccination Product and Solutions
Table 67. Hissen Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Hissen Recent Developments and Future Plans
Table 69. KM Biologics Company Information, Head Office, and Major Competitors
Table 70. KM Biologics Major Business
Table 71. KM Biologics Human Vaccination Product and Solutions
Table 72. KM Biologics Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. KM Biologics Recent Developments and Future Plans
Table 74. LG Life Sciences Company Information, Head Office, and Major Competitors
Table 75. LG Life Sciences Major Business
Table 76. LG Life Sciences Human Vaccination Product and Solutions
Table 77. LG Life Sciences Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. LG Life Sciences Recent Developments and Future Plans
Table 79. Serum Institute Company Information, Head Office, and Major Competitors
Table 80. Serum Institute Major Business
Table 81. Serum Institute Human Vaccination Product and Solutions
Table 82. Serum Institute Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Serum Institute Recent Developments and Future Plans
Table 84. Pfizer Company Information, Head Office, and Major Competitors
Table 85. Pfizer Major Business
Table 86. Pfizer Human Vaccination Product and Solutions
Table 87. Pfizer Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Pfizer Recent Developments and Future Plans
Table 89. Global Human Vaccination Revenue (USD Million) by Players (2020-2025)
Table 90. Global Human Vaccination Revenue Share by Players (2020-2025)
Table 91. Breakdown of Human Vaccination by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in Human Vaccination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 93. Head Office of Key Human Vaccination Players
Table 94. Human Vaccination Market: Company Product Type Footprint
Table 95. Human Vaccination Market: Company Product Application Footprint
Table 96. Human Vaccination New Market Entrants and Barriers to Market Entry
Table 97. Human Vaccination Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Human Vaccination Consumption Value (USD Million) by Type (2020-2025)
Table 99. Global Human Vaccination Consumption Value Share by Type (2020-2025)
Table 100. Global Human Vaccination Consumption Value Forecast by Type (2026-2031)
Table 101. Global Human Vaccination Consumption Value by Application (2020-2025)
Table 102. Global Human Vaccination Consumption Value Forecast by Application (2026-2031)
Table 103. North America Human Vaccination Consumption Value by Type (2020-2025) & (USD Million)
Table 104. North America Human Vaccination Consumption Value by Type (2026-2031) & (USD Million)
Table 105. North America Human Vaccination Consumption Value by Application (2020-2025) & (USD Million)
Table 106. North America Human Vaccination Consumption Value by Application (2026-2031) & (USD Million)
Table 107. North America Human Vaccination Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Human Vaccination Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Human Vaccination Consumption Value by Type (2020-2025) & (USD Million)
Table 110. Europe Human Vaccination Consumption Value by Type (2026-2031) & (USD Million)
Table 111. Europe Human Vaccination Consumption Value by Application (2020-2025) & (USD Million)
Table 112. Europe Human Vaccination Consumption Value by Application (2026-2031) & (USD Million)
Table 113. Europe Human Vaccination Consumption Value by Country (2020-2025) & (USD Million)
Table 114. Europe Human Vaccination Consumption Value by Country (2026-2031) & (USD Million)
Table 115. Asia-Pacific Human Vaccination Consumption Value by Type (2020-2025) & (USD Million)
Table 116. Asia-Pacific Human Vaccination Consumption Value by Type (2026-2031) & (USD Million)
Table 117. Asia-Pacific Human Vaccination Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Asia-Pacific Human Vaccination Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Asia-Pacific Human Vaccination Consumption Value by Region (2020-2025) & (USD Million)
Table 120. Asia-Pacific Human Vaccination Consumption Value by Region (2026-2031) & (USD Million)
Table 121. South America Human Vaccination Consumption Value by Type (2020-2025) & (USD Million)
Table 122. South America Human Vaccination Consumption Value by Type (2026-2031) & (USD Million)
Table 123. South America Human Vaccination Consumption Value by Application (2020-2025) & (USD Million)
Table 124. South America Human Vaccination Consumption Value by Application (2026-2031) & (USD Million)
Table 125. South America Human Vaccination Consumption Value by Country (2020-2025) & (USD Million)
Table 126. South America Human Vaccination Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Middle East & Africa Human Vaccination Consumption Value by Type (2020-2025) & (USD Million)
Table 128. Middle East & Africa Human Vaccination Consumption Value by Type (2026-2031) & (USD Million)
Table 129. Middle East & Africa Human Vaccination Consumption Value by Application (2020-2025) & (USD Million)
Table 130. Middle East & Africa Human Vaccination Consumption Value by Application (2026-2031) & (USD Million)
Table 131. Middle East & Africa Human Vaccination Consumption Value by Country (2020-2025) & (USD Million)
Table 132. Middle East & Africa Human Vaccination Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Global Key Players of Human Vaccination Upstream (Raw Materials)
Table 134. Global Human Vaccination Typical Customers
Table 1. Global Human Vaccination Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Human Vaccination Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Human Vaccination Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Human Vaccination Consumption Value by Region (2026-2031) & (USD Million)
Table 5. GSK Company Information, Head Office, and Major Competitors
Table 6. GSK Major Business
Table 7. GSK Human Vaccination Product and Solutions
Table 8. GSK Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. GSK Recent Developments and Future Plans
Table 10. Merck Company Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Human Vaccination Product and Solutions
Table 13. Merck Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Merck Recent Developments and Future Plans
Table 15. Sanofi Company Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Human Vaccination Product and Solutions
Table 18. Sanofi Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Sinovac Company Information, Head Office, and Major Competitors
Table 20. Sinovac Major Business
Table 21. Sinovac Human Vaccination Product and Solutions
Table 22. Sinovac Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Sinovac Recent Developments and Future Plans
Table 24. Zhejiang Pukang Company Information, Head Office, and Major Competitors
Table 25. Zhejiang Pukang Major Business
Table 26. Zhejiang Pukang Human Vaccination Product and Solutions
Table 27. Zhejiang Pukang Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Zhejiang Pukang Recent Developments and Future Plans
Table 29. Changchun Institute of Biological Company Information, Head Office, and Major Competitors
Table 30. Changchun Institute of Biological Major Business
Table 31. Changchun Institute of Biological Human Vaccination Product and Solutions
Table 32. Changchun Institute of Biological Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Changchun Institute of Biological Recent Developments and Future Plans
Table 34. KM Biologics Company Information, Head Office, and Major Competitors
Table 35. KM Biologics Major Business
Table 36. KM Biologics Human Vaccination Product and Solutions
Table 37. KM Biologics Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. KM Biologics Recent Developments and Future Plans
Table 39. IMBCAMS Company Information, Head Office, and Major Competitors
Table 40. IMBCAMS Major Business
Table 41. IMBCAMS Human Vaccination Product and Solutions
Table 42. IMBCAMS Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. IMBCAMS Recent Developments and Future Plans
Table 44. Convac Company Information, Head Office, and Major Competitors
Table 45. Convac Major Business
Table 46. Convac Human Vaccination Product and Solutions
Table 47. Convac Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Convac Recent Developments and Future Plans
Table 49. NCPC Company Information, Head Office, and Major Competitors
Table 50. NCPC Major Business
Table 51. NCPC Human Vaccination Product and Solutions
Table 52. NCPC Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. NCPC Recent Developments and Future Plans
Table 54. Bio Kangtai Company Information, Head Office, and Major Competitors
Table 55. Bio Kangtai Major Business
Table 56. Bio Kangtai Human Vaccination Product and Solutions
Table 57. Bio Kangtai Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Bio Kangtai Recent Developments and Future Plans
Table 59. Dynavax Company Information, Head Office, and Major Competitors
Table 60. Dynavax Major Business
Table 61. Dynavax Human Vaccination Product and Solutions
Table 62. Dynavax Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Dynavax Recent Developments and Future Plans
Table 64. Hissen Company Information, Head Office, and Major Competitors
Table 65. Hissen Major Business
Table 66. Hissen Human Vaccination Product and Solutions
Table 67. Hissen Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Hissen Recent Developments and Future Plans
Table 69. KM Biologics Company Information, Head Office, and Major Competitors
Table 70. KM Biologics Major Business
Table 71. KM Biologics Human Vaccination Product and Solutions
Table 72. KM Biologics Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. KM Biologics Recent Developments and Future Plans
Table 74. LG Life Sciences Company Information, Head Office, and Major Competitors
Table 75. LG Life Sciences Major Business
Table 76. LG Life Sciences Human Vaccination Product and Solutions
Table 77. LG Life Sciences Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. LG Life Sciences Recent Developments and Future Plans
Table 79. Serum Institute Company Information, Head Office, and Major Competitors
Table 80. Serum Institute Major Business
Table 81. Serum Institute Human Vaccination Product and Solutions
Table 82. Serum Institute Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Serum Institute Recent Developments and Future Plans
Table 84. Pfizer Company Information, Head Office, and Major Competitors
Table 85. Pfizer Major Business
Table 86. Pfizer Human Vaccination Product and Solutions
Table 87. Pfizer Human Vaccination Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Pfizer Recent Developments and Future Plans
Table 89. Global Human Vaccination Revenue (USD Million) by Players (2020-2025)
Table 90. Global Human Vaccination Revenue Share by Players (2020-2025)
Table 91. Breakdown of Human Vaccination by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in Human Vaccination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 93. Head Office of Key Human Vaccination Players
Table 94. Human Vaccination Market: Company Product Type Footprint
Table 95. Human Vaccination Market: Company Product Application Footprint
Table 96. Human Vaccination New Market Entrants and Barriers to Market Entry
Table 97. Human Vaccination Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Human Vaccination Consumption Value (USD Million) by Type (2020-2025)
Table 99. Global Human Vaccination Consumption Value Share by Type (2020-2025)
Table 100. Global Human Vaccination Consumption Value Forecast by Type (2026-2031)
Table 101. Global Human Vaccination Consumption Value by Application (2020-2025)
Table 102. Global Human Vaccination Consumption Value Forecast by Application (2026-2031)
Table 103. North America Human Vaccination Consumption Value by Type (2020-2025) & (USD Million)
Table 104. North America Human Vaccination Consumption Value by Type (2026-2031) & (USD Million)
Table 105. North America Human Vaccination Consumption Value by Application (2020-2025) & (USD Million)
Table 106. North America Human Vaccination Consumption Value by Application (2026-2031) & (USD Million)
Table 107. North America Human Vaccination Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Human Vaccination Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Human Vaccination Consumption Value by Type (2020-2025) & (USD Million)
Table 110. Europe Human Vaccination Consumption Value by Type (2026-2031) & (USD Million)
Table 111. Europe Human Vaccination Consumption Value by Application (2020-2025) & (USD Million)
Table 112. Europe Human Vaccination Consumption Value by Application (2026-2031) & (USD Million)
Table 113. Europe Human Vaccination Consumption Value by Country (2020-2025) & (USD Million)
Table 114. Europe Human Vaccination Consumption Value by Country (2026-2031) & (USD Million)
Table 115. Asia-Pacific Human Vaccination Consumption Value by Type (2020-2025) & (USD Million)
Table 116. Asia-Pacific Human Vaccination Consumption Value by Type (2026-2031) & (USD Million)
Table 117. Asia-Pacific Human Vaccination Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Asia-Pacific Human Vaccination Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Asia-Pacific Human Vaccination Consumption Value by Region (2020-2025) & (USD Million)
Table 120. Asia-Pacific Human Vaccination Consumption Value by Region (2026-2031) & (USD Million)
Table 121. South America Human Vaccination Consumption Value by Type (2020-2025) & (USD Million)
Table 122. South America Human Vaccination Consumption Value by Type (2026-2031) & (USD Million)
Table 123. South America Human Vaccination Consumption Value by Application (2020-2025) & (USD Million)
Table 124. South America Human Vaccination Consumption Value by Application (2026-2031) & (USD Million)
Table 125. South America Human Vaccination Consumption Value by Country (2020-2025) & (USD Million)
Table 126. South America Human Vaccination Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Middle East & Africa Human Vaccination Consumption Value by Type (2020-2025) & (USD Million)
Table 128. Middle East & Africa Human Vaccination Consumption Value by Type (2026-2031) & (USD Million)
Table 129. Middle East & Africa Human Vaccination Consumption Value by Application (2020-2025) & (USD Million)
Table 130. Middle East & Africa Human Vaccination Consumption Value by Application (2026-2031) & (USD Million)
Table 131. Middle East & Africa Human Vaccination Consumption Value by Country (2020-2025) & (USD Million)
Table 132. Middle East & Africa Human Vaccination Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Global Key Players of Human Vaccination Upstream (Raw Materials)
Table 134. Global Human Vaccination Typical Customers
LIST OF FIGURES
Figure 1. Human Vaccination Picture
Figure 2. Global Human Vaccination Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Human Vaccination Consumption Value Market Share by Type in 2024
Figure 4. Inactivated Vaccine
Figure 5. Live-attenuated Vaccine
Figure 6. mRNA Vaccine
Figure 7. Conjugate Vaccine
Figure 8. Other
Figure 9. Global Human Vaccination Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Human Vaccination Consumption Value Market Share by Application in 2024
Figure 11. Government Institution Picture
Figure 12. Private Sector Picture
Figure 13. Other Picture
Figure 14. Global Human Vaccination Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Human Vaccination Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Human Vaccination Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Human Vaccination Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Human Vaccination Consumption Value Market Share by Region in 2024
Figure 19. North America Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Human Vaccination Revenue Share by Players in 2024
Figure 26. Human Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Human Vaccination by Player Revenue in 2024
Figure 28. Top 3 Human Vaccination Players Market Share in 2024
Figure 29. Top 6 Human Vaccination Players Market Share in 2024
Figure 30. Global Human Vaccination Consumption Value Share by Type (2020-2025)
Figure 31. Global Human Vaccination Market Share Forecast by Type (2026-2031)
Figure 32. Global Human Vaccination Consumption Value Share by Application (2020-2025)
Figure 33. Global Human Vaccination Market Share Forecast by Application (2026-2031)
Figure 34. North America Human Vaccination Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Human Vaccination Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Human Vaccination Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Human Vaccination Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Human Vaccination Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Human Vaccination Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 44. France Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Human Vaccination Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Human Vaccination Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Human Vaccination Consumption Value Market Share by Region (2020-2031)
Figure 51. China Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 54. India Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Human Vaccination Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Human Vaccination Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Human Vaccination Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Human Vaccination Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Human Vaccination Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Human Vaccination Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 68. Human Vaccination Market Drivers
Figure 69. Human Vaccination Market Restraints
Figure 70. Human Vaccination Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Human Vaccination Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Human Vaccination Picture
Figure 2. Global Human Vaccination Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Human Vaccination Consumption Value Market Share by Type in 2024
Figure 4. Inactivated Vaccine
Figure 5. Live-attenuated Vaccine
Figure 6. mRNA Vaccine
Figure 7. Conjugate Vaccine
Figure 8. Other
Figure 9. Global Human Vaccination Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Human Vaccination Consumption Value Market Share by Application in 2024
Figure 11. Government Institution Picture
Figure 12. Private Sector Picture
Figure 13. Other Picture
Figure 14. Global Human Vaccination Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Human Vaccination Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Human Vaccination Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Human Vaccination Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Human Vaccination Consumption Value Market Share by Region in 2024
Figure 19. North America Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Human Vaccination Revenue Share by Players in 2024
Figure 26. Human Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Human Vaccination by Player Revenue in 2024
Figure 28. Top 3 Human Vaccination Players Market Share in 2024
Figure 29. Top 6 Human Vaccination Players Market Share in 2024
Figure 30. Global Human Vaccination Consumption Value Share by Type (2020-2025)
Figure 31. Global Human Vaccination Market Share Forecast by Type (2026-2031)
Figure 32. Global Human Vaccination Consumption Value Share by Application (2020-2025)
Figure 33. Global Human Vaccination Market Share Forecast by Application (2026-2031)
Figure 34. North America Human Vaccination Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Human Vaccination Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Human Vaccination Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Human Vaccination Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Human Vaccination Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Human Vaccination Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 44. France Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Human Vaccination Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Human Vaccination Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Human Vaccination Consumption Value Market Share by Region (2020-2031)
Figure 51. China Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 54. India Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Human Vaccination Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Human Vaccination Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Human Vaccination Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Human Vaccination Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Human Vaccination Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Human Vaccination Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Human Vaccination Consumption Value (2020-2031) & (USD Million)
Figure 68. Human Vaccination Market Drivers
Figure 69. Human Vaccination Market Restraints
Figure 70. Human Vaccination Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Human Vaccination Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
